More on MET

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+16.8% Growth)
- Ratings (6.7 Score)
- Holders
- Dividends (2.6% Yield)
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/5/26)
- Ex-Dividend (8/3/2026)
- Spin-Off (N/A)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

MET Balance Sheet

Click line-items for a historical chart and %
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $330,903 and $317,617, respectively; includes $3,357 and $3,330, respectively, relating to variable interest entities) 390.44B
Equity securities available-for-sale, at estimated fair value (cost: $3,128 and $3,621, respectively) 3.29B
Trading and other securities, at estimated fair value (includes $560 and $463, respectively, of actively traded securities; and $359 and $387, respectively, relating to variable interest entities)
Held-for-investment, principally at amortized cost (net of valuation allowances of $566 and $664, respectively; includes $6,697 and $6,840, respectively, at estimated fair value, relating to variable interest entities)
Held-for-sale, principally at estimated fair value
Mortgage loans, net 71.16B
Policy loans 11.18B
Real estate and real estate joint ventures (includes $15 and $10, respectively, relating to variable interest entities)
Other limited partnership interests (includes $331 and $298, respectively, relating to variable interest entities) 6.88B
Short-term investments, principally at estimated fair value 11.66B
Other invested assets, principally at estimated fair value (includes $98 and $104, respectively, relating to variable interest entities) 30.28B
Total investments 548.79B
Cash and cash equivalents, principally at estimated fair value (includes $65 and $69, respectively, relating to variable interest entities) 15.88B
Accrued investment income (includes $34 and $34, respectively, relating to variable interest entities) 4.2B
Premiums, reinsurance and other receivables (includes $2 and $2, respectively, relating to variable interest entities) 26.18B
Deferred policy acquisition costs and value of business acquired 24.75B
Goodwill 9.59B
Other assets (includes $7 and $6, respectively, relating to variable interest entities) 7.87B
Assets of subsidiaries held-for-sale
Separate account assets 315.65B
Total assets 952.9B
Future policy benefits 208.56B
Policyholder account balances 216.19B
Other policy-related balances 14.86B
Policyholder dividends payable 763M
Policyholder dividend obligation 3.35B
Payables for collateral under securities loaned and other transactions
Bank deposits
Short-term debt 201M
Long-term debt (includes $6,569 and $6,902, respectively, at estimated fair value, relating to variable interest entities)
Collateral financing arrangements 4.08B
Junior subordinated debt securities 3.17B
Current income tax payable 151M
Deferred income tax liability
Other liabilities (includes $82 and $93, respectively, relating to variable interest entities) 32.13B
Liabilities of subsidiaries held-for-sale
Separate account liabilities 315.65B
Total liabilities 874.44B
Contingencies, Commitments and Guarantees (Note 8)
Redeemable noncontrolling interests in partially owned consolidated subsidiaries
MetLife, Inc.'s stockholders' equity:
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,060,584,995 and 989,031,704 shares issued at June 30, 2011 and December 31, 2010, respectively; 1,057,391,108 and 985,837,817 shares outstanding at June 30, 2011 and December 31, 2010, respectively 12M
Additional paid-in capital 30.8B
Retained earnings 37.05B
Treasury stock, at cost; 3,193,887 shares at June 30, 2011 and December 31, 2010 -3.17B
Accumulated other comprehensive income (loss) 13.6B
Total MetLife, Inc.'s stockholders' equity 78.29B
Noncontrolling interests 180M
Total equity 78.47B
Total liabilities and equity 952.9B
MetLife, Inc.'s stockholders' equity:
Preferred Stock 0
Total equity
MetLife, Inc.'s stockholders' equity:
Preferred Stock
Total equity